期刊文献+

1997~2001年不动杆菌属临床分离株分布特点和耐药性分析 被引量:14

Study on Antimicrobial Resistance of Acinetobacter spp. in 1997-2001
下载PDF
导出
摘要 目的探讨临床分离的不动杆菌属细菌在患者、季节性分布特点和耐药性现状。方法:1.菌种鉴定采用常规方法或用API试条和VITEK自动细菌分析仪;2.用WHONET5软件对不动杆菌菌种分布和药敏试验结果(Kirby-Baner纸片扩散法)进行了统计分析。结果:1.临床分离的不动杆菌属细菌的标本来源主要以痰标本为主(74%);鲍曼不动杆菌是最常见的菌种,检出数列临床常见细菌第八位;鲍曼不动杆菌的流行呈季节性分布,在潮热的夏季检出量大,在60岁以上老年人中的检出数占其总检出数的40.1%;2,鲍曼不动杆菌耐药谱分析结果表明,在二重耐药谱中以耐头孢他啶和哌拉西林多见(CP、4%);三重耐药谱中主要为耐头孢他啶、环丙沙星和哌拉西林为主(CRP、10%);四重耐药谱中以耐阿米卡星、头孢他啶、环丙沙星和哌拉西林为主(ACRP、15%)。结论:对临床分离的鲍曼不动杆菌应加强季节性和易感人群的耐药性监测,密切注意多重耐药株的出现。 OBJECTIVE: To investigate the antimicrobial resistance of clinical isolates of Acinetobacter spp. during a 5-year period of 1997-2001 in China. METHODS: The strains of Acinetobacter spp. were identified by the routine methods. Disc diffusion test (Kirby-Bauer method) was used to study the antimicrobial susceptibility. The data was analyzed by WHONET5 sofeware. RESULTS: The isolate rate of Acinetobacter baumannii among all clinical bacterial isolates was 4%. Acinetobacter baumannii was the most common strain in Acinetobacter spp., and was prevalent in the warmer and humid months of the year, It was commonly isolated from the old patients' and the aspiratory tract's specimens. Resistance profiles of Acinetobacter baumanni to amikacin(A), ceftazidime(C), ciprofloxacin (R), impenem(I), pipracillin(P) were analy sised. The major multidrug-resistant profiles were CR P(10%), ACR P(15%). CONCLUSIONS: It is important to surveillance antimicrobial susceptibility and multidrug resistant profiles of Acinetobacter spp..
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2002年第6期421-424,共4页 The Chinese Journal of Clinical Pharmacology
关键词 分布特点 不动杆菌属 K-B纸片扩散法 耐药性 多重耐药谱 Acinetobacter spp., disc diffusion test (Kirby-Bauer method), antimicrobiol resistance, multidrug-resistance profile
  • 相关文献

参考文献11

  • 1Paul CS, Alexander VG.Acinetobacter, Achromobacter, Alcaligenes,Moraxella, Methylobacterium, and OtherNonfermentative GramNegative Rods. P R.Murray, E J.Baron, M A.Pfaller, et al. Mannal ofclinical microbiology,7th edition.539~543.
  • 2Valero C,Garcia Palomo JD, Matorras P, et al. Acinetobater bacteraemia in ateaching hospital,1989-1998. Eux J Intem Med,2001; 12:425~429.
  • 3The cost of antibiotic resistance: effect of resistance among Staphylococcusaureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudmonas aeruginosa onlength of hospital stay.Infect Control Hosp Epidemiol,2002;Feb;23:106~108.
  • 4National Committee for Clinical Laboratory Standards 2001.Performance standards forantimicrobial susceptibility testing. l lth information supplment. NCCLS document M100-S11 National Committee for Clinical Laboratory Standards, Wayne, Pa.
  • 5Srifuengfung S, Sangsawang M, Komolpis P, et al. Bacterial pathogens(non-Mycobacterium) from sputum culture and antimicrobial susceptibility. Southeast AsianJ Trop Med Public Health, 1998 ;29:96~99.
  • 6Chen MZ, Hsueh PR, Lee LN, et al. Severe Community-Acquired Pneumonia due toAcinetobacter baumannii. Chest, 2001; 120:1072~1077.
  • 7Koeleman JG, Van der Bijl MW, Stoof J, et al. Antibiotic resistance is a major riskfactor for epidemic behavior of Acinetobacter baumannii. Infect control HospEpidemiol,2001 ;22:284~288.
  • 8Roberts SA, Findlay R, Lang SD. estigation of an outbreak of multidrug resistanceAcinetobacter baumannii in an intensive care burn units.J Hosp Infect,2001 ;48:228~232.
  • 9Simhon A, Rahav G, Shazberg G, et al, Acinetobacter baumannii at a tertiary-careteaching hospital in Jerusalem, Israel. J Clin Microbiol,2001 ;39:389~391.
  • 10Bello H, Dominguez M, Sepulveda F, et al. Activity of impenem and meropenemagainst strains of Acinetobacter baumannii isolated from various Chilean Hospitals. RevEsp Quimioter,2000;13:405~407.

同被引文献103

引证文献14

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部